HomePER • ASX
add
Percheron Therapeutics Ltd
Previous close
$0.0080
Day range
$0.0070 - $0.0080
Year range
$0.0050 - $0.089
Market cap
6.96M AUD
Avg Volume
2.20M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 824.64K | -6.72% |
Operating expense | 4.01M | -10.09% |
Net income | -3.19M | 11.01% |
Net profit margin | -387.20 | 4.60% |
Earnings per share | — | — |
EBITDA | -3.21M | 10.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.17M | -14.32% |
Total assets | 12.44M | -14.41% |
Total liabilities | 2.43M | -52.93% |
Total equity | 10.00M | — |
Shares outstanding | 1.09B | — |
Price to book | 0.80 | — |
Return on assets | -64.80% | — |
Return on capital | -80.34% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.19M | 11.01% |
Cash from operations | -3.59M | -33.61% |
Cash from investing | 1.00 | -99.93% |
Cash from financing | -22.72K | -211.98% |
Net change in cash | -3.61M | -35.56% |
Free cash flow | -1.44M | 34.14% |
About
CEO
Founded
2000
Headquarters
Website
Employees
8
